Advertisement
U.S. markets close in 2 hours 33 minutes

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - Nasdaq Real Time Price. Currency in USD
1.2600+0.0100 (+0.80%)
As of 01:25PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.2500
Open1.2400
Bid1.2600 x 1200
Ask1.2700 x 1300
Day's Range1.2500 - 1.2800
52 Week Range1.2100 - 3.5500
Volume138,361
Avg. Volume328,621
Market Cap92.046M
Beta (5Y Monthly)0.91
PE Ratio (TTM)14.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
29% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PLX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Protalix BioTherapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/23/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more